Since all cHCC-CCA and CCA were highly positive for cytoplasmic and nuclear YAP and TAZ, it was not possible to perform a survival analysis based on the expression of YAP or TAZ in these tumors. This evidence concerns the gene YAP1 and cholangiocarcinoma.